Algert Global LLC Precision Biosciences Inc Transaction History
Algert Global LLC
- $4.25 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding DTIL
# of Institutions
7Shares Held
2.56MCall Options Held
0Put Options Held
0-
Oup Management Co., LLC1.12MShares$5.89 Million0.86% of portfolio
-
Chi Advisors LLC New York, NY607KShares$3.18 Million0.1% of portfolio
-
Jacob Asset Management Of New York LLC Hermosa Beach, CA390KShares$2.05 Million0.19% of portfolio
-
Tekla Capital Management LLC225KShares$1.18 Million0.0% of portfolio
-
Vericrest Private Wealth Newtown, PA155KShares$810,5960.3% of portfolio
About PRECISION BIOSCIENCES INC
- Ticker DTIL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 110,818,000
- Market Cap $581M
- Description
- Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...